Basic Information
ONGLYZA
55154-6931
Regulatory Information
55154-6931
NDA022350
C73594
December 30, 2019
USA
These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets, for oral useInitial U.S. Approval: 2009
HUMAN PRESCRIPTION DRUG LABEL
11
Company Information
118546603
Active Ingredients
lactose monohydrate
Code: EWQ57Q8I5X
Class Code: IACT
MICROCRYSTALLINE CELLULOSE
Code: OP1R32D61U
Class Code: IACT
croscarmellose sodium
Code: M28OL1HH48
Class Code: IACT
magnesium stearate
Code: 70097M6I30
Class Code: IACT
Active Moieties
saxagliptin anhydrous
Code: 8I7IO46IVQ